Electronic alerts to reduce heart medication overuse in older adults
This study tests whether electronic alerts in hospitals help doctors avoid prescribing too much digoxin (a heart medication) in older adults, reducing the risk of side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- You are currently admitted to a hospital inpatient ward
- Your medical records contain the information needed for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether digoxin, a heart medication, can reduce harmful aging-related changes in heart failure patients who also have type 2 diabetes. It aims to improve heart function and potentially slow disease progression.
This trial tests whether digoxin, a heart medication, can help people who were recently hospitalized for heart failure with a weak heart pump. It aims to see if it improves symptoms and daily activity.
This study tests whether digital reminders (like texts or automated calls) can help people with heart failure remember to refill their medications on time. If you've recently missed a refill, this program could help you stay on track.
This study looks at whether certain medicines cause unwanted side effects (iatrogenic drug events) in adults over 65 who come to the emergency department of Hautepierre Hospital. It hopes to find ways to make medications safer for older patients.
This trial tests whether giving doctors regular feedback can help reduce prescriptions of certain medicines (sleeping pills, acid reducers, and painkillers) that may be risky for older people. If you are 65 or older and take one of these medicines long-term, the study aims to improve your care by helping your doctor review if the medicine is still needed.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Hear when a new Drug-Related Side Effects and Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.